Literature DB >> 22266725

GPCRs and cancer.

Rosamaria Lappano1, Marcello Maggiolini.   

Abstract

G-protein-coupled receptors (GPCRs), which represent the largest gene family in the human genome, play a crucial role in multiple physiological functions as well as in tumor growth and metastasis. For instance, various molecules like hormones, lipids, peptides and neurotransmitters exert their biological effects by binding to these seven-transmembrane receptors coupled to heterotrimeric G-proteins, which are highly specialized transducers able to modulate diverse signaling pathways. Furthermore, numerous responses mediated by GPCRs are not dependent on a single biochemical route, but result from the integration of an intricate network of transduction cascades involved in many physiological activities and tumor development. This review highlights the emerging information on the various responses mediated by a selected choice of GPCRs and the molecular mechanisms by which these receptors exert a primary action in cancer progression. These findings provide a broad overview on the biological activity elicited by GPCRs in tumor cells and contribute to the identification of novel pharmacological approaches for cancer patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266725      PMCID: PMC4077134          DOI: 10.1038/aps.2011.183

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  182 in total

1.  Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity.

Authors:  Samer Singh; Zhiqiang Wang; Dennis Liang Fei; Kendall E Black; John A Goetz; Robert Tokhunts; Camilla Giambelli; Jezabel Rodriguez-Blanco; Jun Long; Ethan Lee; Karoline J Briegel; Pablo A Bejarano; Ethan Dmitrovsky; Anthony J Capobianco; David J Robbins
Journal:  Cancer Res       Date:  2011-05-12       Impact factor: 12.701

2.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Authors:  Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland Foshag; Anton J Bilchik; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

3.  Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.

Authors:  Thierry Voisin; Aadil El Firar; Magali Fasseu; Christiane Rouyer-Fessard; Véronique Descatoire; Francine Walker; Valérie Paradis; Pierre Bedossa; Dominique Henin; Thérèse Lehy; Marc Laburthe
Journal:  Cancer Res       Date:  2011-03-17       Impact factor: 12.701

4.  Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  P Desch; D Asslaber; D Kern; H Schnidar; D Mangelberger; B Alinger; M Stoecher; S W Hofbauer; D Neureiter; I Tinhofer; F Aberger; T N Hartmann; R Greil
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

5.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

Authors:  Adele Vivacqua; Daniela Bonofiglio; Anna Grazia Recchia; Anna Maria Musti; Didier Picard; Sebastiano Andò; Marcello Maggiolini
Journal:  Mol Endocrinol       Date:  2005-10-20

6.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

Review 7.  Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.

Authors:  Suzie J Scales; Frederic J de Sauvage
Journal:  Trends Pharmacol Sci       Date:  2009-05-13       Impact factor: 14.819

8.  Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.

Authors:  Dai Shida; Toshiaki Watanabe; Junken Aoki; Kotaro Hama; Joji Kitayama; Hirofumi Sonoda; Yasuhiro Kishi; Hironori Yamaguchi; Shin Sasaki; Akihiro Sako; Tsuyoshi Konishi; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

9.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

10.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF.

Authors:  Deo Prakash Pandey; Rosamaria Lappano; Lidia Albanito; Antonio Madeo; Marcello Maggiolini; Didier Picard
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

View more
  39 in total

1.  A new era for GPCR research: structures, biology and drug discovery.

Authors:  H Eric Xu; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-03       Impact factor: 6.150

2.  SeQuery: an interactive graph database for visualizing the GPCR superfamily.

Authors:  Geng-Ming Hu; M K Secario; Chi-Ming Chen
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

Review 3.  Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

4.  Monitoring endosomal trafficking of the g protein-coupled receptor somatostatin receptor 3.

Authors:  Cristy Tower-Gilchrist; Melanie L Styers; Bradley K Yoder; Nicolas F Berbari; Elizabeth Sztul
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

5.  Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.

Authors:  Jin-Ku Lee; DO-Hyun Nam; Jeongwu Lee
Journal:  Oncol Lett       Date:  2016-01-07       Impact factor: 2.967

6.  MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Patrick J Casey
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

7.  The N-terminus of the yeast G protein-coupled receptor Ste2p plays critical roles in surface expression, signaling, and negative regulation.

Authors:  M Seraj Uddin; Melinda Hauser; Fred Naider; Jeffrey M Becker
Journal:  Biochim Biophys Acta       Date:  2015-12-17

8.  Structural Basis of the Activation of Heterotrimeric Gs-Protein by Isoproterenol-Bound β1-Adrenergic Receptor.

Authors:  Minfei Su; Lan Zhu; Yixiao Zhang; Navid Paknejad; Raja Dey; Jianyun Huang; Ming-Yue Lee; Dewight Williams; Kelsey D Jordan; Edward T Eng; Oliver P Ernst; Joel R Meyerson; Richard K Hite; Thomas Walz; Wei Liu; Xin-Yun Huang
Journal:  Mol Cell       Date:  2020-08-19       Impact factor: 17.970

Review 9.  Regulation, Signaling, and Physiological Functions of G-Proteins.

Authors:  Viktoriya Syrovatkina; Kamela O Alegre; Raja Dey; Xin-Yun Huang
Journal:  J Mol Biol       Date:  2016-08-08       Impact factor: 5.469

Review 10.  The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis.

Authors:  Anna Skorupska; Rafał Lenda; Andrzej Ożyhar; Dominika Bystranowska
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.